After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

In its third-quarter results update, Sanofi said the consumer health unit – which owns brands ... The range of consumer healthcare products it offers will also be “streamlined” ahead of ...

Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for ... a good fit with its existing business in terms of products and geographies, giving it much increased ...

Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank ...

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines.

The French pharmaceutical company Sanofi SA has received mandatory offers to acquire the Consumer Health division from private equity firms Clayton Dubilier & Rice and PAI Partners. This is reported ...

Kennedy Jr., a vaccine skeptic, as the head of Health and Human Services ... backed by its innovation efforts. Sanofi’s new products like novel recombinant factor VIII therapy, Altuviiio ...

The deal also allows Sanofi to use Novavax's Covid shot and flagship vaccine technology, Matrix-M adjuvant, to develop new ...

Sanofi's consumer healthcare business' annual turnover for FY2022 stood at Rs 730 crore. The company's top consumer healthcare brands include Allegra, DePURA, Avil, and Combiflam.